Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7076
Rank
ยฃ0.46 B
Marketcap
ยฃ13.28
Share price
-0.91%
Change (1 day)
-46.98%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total debt

Total debt on the balance sheet as of June 2026 : ยฃ23.42 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total debt is ยฃ23.42 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Avalon Pharma (Middle East Pharmaceutical) - Total debt on balance sheet (from 2023 to 2026)

Total debt by year

Year Total debt Change
2025-12-31ยฃ12.64 M-5.85%
2024-12-31ยฃ13.43 M3.39%
2023-12-31ยฃ12.99 M